Pharmacological therapeutics in Friedreich ataxia: the present state.
about
Liquid Chromatography-High Resolution Mass Spectrometry Analysis of Platelet Frataxin as a Protein Biomarker for the Rare Disease Friedreich's Ataxia.Idebenone: Novel Strategies to Improve Its Systemic and Local Efficacy.Low apolipoprotein A-I levels in Friedreich's ataxia and in frataxin-deficient cells: Implications for therapy.Clinical and genetic aspects of defects in the mitochondrial iron-sulfur cluster synthesis pathway.
P2860
Pharmacological therapeutics in Friedreich ataxia: the present state.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Pharmacological therapeutics in Friedreich ataxia: the present state.
@en
Pharmacological therapeutics in Friedreich ataxia: the present state.
@nl
type
label
Pharmacological therapeutics in Friedreich ataxia: the present state.
@en
Pharmacological therapeutics in Friedreich ataxia: the present state.
@nl
prefLabel
Pharmacological therapeutics in Friedreich ataxia: the present state.
@en
Pharmacological therapeutics in Friedreich ataxia: the present state.
@nl
P2093
P2860
P1476
Pharmacological therapeutics in Friedreich ataxia: the present state.
@en
P2093
Ashley McCormick
Cassandra Strawser
David R Lynch
Jane Larkindale
Kimberly Schadt
Lauren Hauser
McKenzie Wells
P2860
P304
P356
10.1080/14737175.2017.1356721
P577
2017-07-20T00:00:00Z